Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

NCT01420250 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Cabazitaxel
RADIATION: Intensity Modulated Radiation Therapy (IMRT)
DRUG: Anti-Androgen Therapy: Bicalutamide
GENETIC: Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]